Allred Capital Management’s Biogen BIIB Stock Holding History

Allred Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-299	Closed	-$83.6K	–	252
2021 Q1	$83.6K	Buy	+299	New	+$80.6K	0.04%	295
2020 Q1	–	Sell	-310	Closed	-$92K	–	199
2019 Q4	$92K	Buy	+310	New	+$86K	0.05%	224
2019 Q3	–	Sell	-891	Closed	-$210K	–	166
2019 Q2	$210K	Sell	891 -500	-36%	-$115K	0.12%	165
2019 Q1	$324K	Sell	1,391 -365	-21%	-$115K	0.18%	136
2018 Q4	$526K	Buy	+1,756	New	+$560K	0.35%	88

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Allred Capital Management's BIIB Position: Q2 2021 in Review

Allred Capital Management sold out of Biogen (BIIB) in Q2 2021, closing a stake of 299 shares — an estimated $83.6K sold.

Allred Capital Management first reported a position in BIIB in Q4 2018 and held it in 5 quarters. The position peaked at $526K in Q4 2018. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Allred Capital Management reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
Allred Capital Management sold 299 Biogen shares in Q2 2021, an estimated $83.6K.
Allred Capital Management first reported a position in Biogen in Q4 2018 and held it in 5 quarters.
Allred Capital Management's Biogen position peaked at $526K in Q4 2018.
1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Allred Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.